GAMMAGARD LIQUID for Immunodeficiency common variable: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 81 adverse event reports in the FDA FAERS database where GAMMAGARD LIQUID was used for Immunodeficiency common variable.
Most Reported Side Effects for GAMMAGARD LIQUID
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Headache | 66 | 13.1% | 0 | 9 |
| Drug ineffective | 44 | 8.8% | 4 | 1 |
| Malaise | 38 | 7.6% | 0 | 6 |
| Sinusitis | 37 | 7.4% | 0 | 4 |
| Nausea | 34 | 6.8% | 0 | 5 |
| Fatigue | 27 | 5.4% | 0 | 2 |
| Pneumonia | 27 | 5.4% | 2 | 11 |
| Pyrexia | 25 | 5.0% | 0 | 5 |
| Dyspnoea | 24 | 4.8% | 1 | 8 |
| Chills | 20 | 4.0% | 0 | 5 |
| Vomiting | 20 | 4.0% | 0 | 8 |
| Bronchitis | 19 | 3.8% | 0 | 1 |
| Death | 15 | 3.0% | 15 | 1 |
| Infection | 15 | 3.0% | 0 | 4 |
| Migraine | 13 | 2.6% | 0 | 4 |
Other Indications for GAMMAGARD LIQUID
Product used for unknown indication (179)
Off label use (57)
Muscular weakness (28)
Hypogammaglobulinaemia (26)
Primary immunodeficiency syndrome (26)
Immunodeficiency (20)
Selective igg subclass deficiency (15)
Immune thrombocytopenic purpura (11)
Myasthenia gravis (8)
Neuropathy peripheral (7)
Other Drugs Used for Immunodeficiency common variable
HUMAN IMMUNOGLOBULIN G (17,389)
HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN (1,598)
HUMAN IMMUNOGLOBULIN G\HYALURONIDASE (881)
HIZENTRA (76)
DUPILUMAB (69)
RITUXIMAB (44)
INFLIXIMAB (28)
PREDNISOLONE (27)
HUMAN C1-ESTERASE INHIBITOR (24)
MYCOPHENOLATE MOFETIL (24)